Humana & Icon Enhance Senior Healthcare With Integrated Specialty Care

18.03.25 17:25 Uhr

Werte in diesem Artikel
Aktien

245,20 EUR -0,20 EUR -0,08%

Indizes

5.667,6 PKT 4,7 PKT 0,08%

Humana Inc.’s HUM senior-focused primary care providers, CenterWell and Conviva, have partnered with Icon Health to enhance access to musculoskeletal care for seniors. This initiative, set to launch in Palm Beach County, will integrate musculoskeletal specialists within primary care centers, ensuring a streamlined and high-quality care experience for elderly patients.This collaboration is expected to bolster HUM’s CenterWell segment, which saw an 8.9% year-over-year revenue increase in the fourth quarter of 2024. Expanding service offerings under value-based contracts could further drive growth. Musculoskeletal conditions are major contributors to disability among seniors, often requiring multi-specialist care. By embedding advanced practice providers within primary care settings, this initiative aims to simplify access to comprehensive treatment, improving both patient outcomes and convenience. The model provides both in-person and virtual care options to cater to the diverse needs of patients.For HUM, this partnership reinforces its commitment to value-based care, strengthening its position as an innovator in senior healthcare. By addressing musculoskeletal issues through early intervention and coordinated care, the initiative is expected to reduce emergency room visits and hospital admissions, resulting in improved patient health and increased operational efficiency. These factors could contribute to cost savings and have a positive impact on HUM’s financial performance.By providing seamless access to specialized care, CenterWell is well-positioned to attract more seniors looking for integrated healthcare solutions. As value-based care continues to shape the industry, HUM’s investment in comprehensive musculoskeletal services supports its long-term growth strategy and competitive edge in senior healthcare.Price PerformanceShares of Humana have gained 12.1% over the past three months, outperforming the industry’s 4.1% growth.Image Source: Zacks Investment ResearchZacks Rank & Stocks to ConsiderHumana currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the broader Medical sector are Pediatrix Medical Group, Inc. MD, The Ensign Group, Inc. ENSG and Addus HomeCare Corporation ADUS. While Pediatrix Medical currently sports a Zacks Rank #1 (Strong Buy), Ensign and Addus HomeCare carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Pediatrix Medical’s current-year earnings increased 3 cents in the past week. MD beat earnings estimates in each of the trailing four quarters, with an average surprise of 19.4%. The consensus mark for its current-year revenues is pegged at $1.9 billion.The Zacks Consensus Estimate for Ensign’s current-year earnings indicates 13.5% year-over-year growth. ENSG beat earnings estimates in each of the trailing four quarters, with an average surprise of 1.5%. The consensus mark for revenues implies a 14.3% increase from the year-ago period.The Zacks Consensus Estimate for Addus HomeCare’s current-year earnings indicates a 13.5% increase from the year-ago reported figure. ADUS beat earnings estimates in three of the trailing four quarters and met once, with an average surprise of 5.8%. The consensus mark for its current-year revenues is pegged at $1.4 billion, which indicates 21.7% year-over-year growth.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Humana Inc. (HUM): Free Stock Analysis Report Pediatrix Medical Group, Inc. (MD): Free Stock Analysis Report Addus HomeCare Corporation (ADUS): Free Stock Analysis Report The Ensign Group, Inc. (ENSG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Humana und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Humana

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Humana

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Humana Inc.

Wer­bung

Analysen zu Humana Inc.

DatumRatingAnalyst
12.08.2019Humana OverweightCantor Fitzgerald
13.09.2018Humana OverweightBarclays Capital
09.11.2017Humana Sector PerformRBC Capital Markets
20.10.2017Humana OutperformBMO Capital Markets
05.04.2017Humana HoldDeutsche Bank AG
DatumRatingAnalyst
12.08.2019Humana OverweightCantor Fitzgerald
13.09.2018Humana OverweightBarclays Capital
20.10.2017Humana OutperformBMO Capital Markets
24.01.2017Humana HoldStifel, Nicolaus & Co., Inc.
05.05.2016Humana BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
09.11.2017Humana Sector PerformRBC Capital Markets
05.04.2017Humana HoldDeutsche Bank AG
07.12.2016Humana HoldCantor Fitzgerald
13.10.2016Humana Sector PerformRBC Capital Markets
22.07.2016Humana Mkt PerformFBR Capital
DatumRatingAnalyst
14.03.2008Humana neues KurszielLehman Brothers Inc.
03.02.2006Update Humana Inc.: UnderperformCredit Suisse First Boston
26.01.2006Update Humana Inc.: ReduceUBS

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Humana Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen